Pharma Foods International Co., Ltd. (PMDSF)
6.40
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Pharma Foods International Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2025 | 79.20% |
| January 31, 2025 | |
| October 31, 2024 | 81.41% |
| July 31, 2024 | 76.34% |
| April 30, 2024 | 78.50% |
| January 31, 2024 | 79.58% |
| October 31, 2023 | 78.65% |
| July 31, 2023 | 80.77% |
| April 30, 2023 | 79.94% |
| January 31, 2023 | 80.28% |
| October 31, 2022 | 81.09% |
| July 31, 2022 | 79.76% |
| April 30, 2022 | 79.94% |
| January 31, 2022 | 76.08% |
| October 31, 2021 | 84.71% |
| July 31, 2021 | 84.81% |
| April 30, 2021 | 85.24% |
| January 31, 2021 | 85.25% |
| October 31, 2020 | 83.88% |
| July 31, 2020 | 78.94% |
| April 30, 2020 | 79.14% |
| January 31, 2020 | 80.97% |
| October 31, 2019 | 77.00% |
| July 31, 2019 | 77.51% |
| April 30, 2019 | 82.14% |
| Date | Value |
|---|---|
| January 31, 2019 | 81.74% |
| October 31, 2018 | 81.41% |
| July 31, 2018 | 77.91% |
| April 30, 2018 | 80.48% |
| January 31, 2018 | 79.80% |
| October 31, 2017 | 79.67% |
| July 31, 2017 | 76.23% |
| April 30, 2017 | 79.77% |
| January 31, 2017 | 80.58% |
| October 31, 2016 | 76.04% |
| July 31, 2016 | 71.12% |
| April 30, 2016 | 74.51% |
| January 31, 2016 | 68.72% |
| October 31, 2015 | 67.24% |
| July 31, 2015 | 65.23% |
| April 30, 2015 | 62.86% |
| January 31, 2015 | 63.40% |
| October 31, 2014 | 55.05% |
| July 31, 2014 | 54.57% |
| April 30, 2014 | 55.22% |
| January 31, 2014 | 56.73% |
| October 31, 2013 | 54.67% |
| July 31, 2013 | 64.34% |
| April 30, 2013 | 50.98% |
| January 31, 2013 | 44.69% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| PeptiDream Inc. | 43.48% |
| Arrowhead Pharmaceuticals, Inc. | 91.15% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | 39.18% |
| Sarepta Therapeutics, Inc. | 60.18% |